Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

BACKGROUND: This post hoc subgroup analysis evaluated the efficacy and safety of eptinezumab for migraine prevention in patients with migraine and self-reported aura. METHODS: PROMISE-1 (NCT02559895; episodic migraine) and PROMISE-2 (NCT02974153; chronic migraine) were randomized, double-blind, plac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashina, Messoud, McAllister, Peter, Cady, Roger, Hirman, Joe, Ettrup, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218409/
https://www.ncbi.nlm.nih.gov/pubmed/35302389
http://dx.doi.org/10.1177/03331024221077646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218409/
https://www.ncbi.nlm.nih.gov/pubmed/35302389
http://dx.doi.org/10.1177/03331024221077646

Ejemplares similares